232 related articles for article (PubMed ID: 15537447)
1. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.
Holmen SL; Giambernardi TA; Zylstra CR; Buckner-Berghuis BD; Resau JH; Hess JF; Glatt V; Bouxsein ML; Ai M; Warman ML; Williams BO
J Bone Miner Res; 2004 Dec; 19(12):2033-40. PubMed ID: 15537447
[TBL] [Abstract][Full Text] [Related]
2. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice.
Kelly OG; Pinson KI; Skarnes WC
Development; 2004 Jun; 131(12):2803-15. PubMed ID: 15142971
[TBL] [Abstract][Full Text] [Related]
3. Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6.
MacDonald BT; Adamska M; Meisler MH
Development; 2004 Jun; 131(11):2543-52. PubMed ID: 15115753
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6.
Fleury D; Vayssiere B; Touitou R; Gillard C; Lebhar H; Rawadi G; Mollat P
Protein Expr Purif; 2010 Mar; 70(1):39-47. PubMed ID: 19716419
[TBL] [Abstract][Full Text] [Related]
5. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
6. Genetic interaction between Wnt7a and Lrp6 during patterning of dorsal and posterior structures of the mouse limb.
Adamska M; Billi AC; Cheek S; Meisler MH
Dev Dyn; 2005 Jun; 233(2):368-72. PubMed ID: 15880584
[TBL] [Abstract][Full Text] [Related]
7. Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd.
Kubota T; Michigami T; Sakaguchi N; Kokubu C; Suzuki A; Namba N; Sakai N; Nakajima S; Imai K; Ozono K
J Bone Miner Res; 2008 Oct; 23(10):1661-71. PubMed ID: 18505367
[TBL] [Abstract][Full Text] [Related]
8. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
[TBL] [Abstract][Full Text] [Related]
9. The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
Johnson ML
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):135-8. PubMed ID: 15615112
[TBL] [Abstract][Full Text] [Related]
10. R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis.
Bell SM; Schreiner CM; Wert SE; Mucenski ML; Scott WJ; Whitsett JA
Development; 2008 Mar; 135(6):1049-58. PubMed ID: 18256198
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
12. LRP5 and Wnt signaling: a union made for bone.
Johnson ML; Harnish K; Nusse R; Van Hul W
J Bone Miner Res; 2004 Nov; 19(11):1749-57. PubMed ID: 15476573
[No Abstract] [Full Text] [Related]
13. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.
Qin M; Hayashi H; Oshima K; Tahira T; Hayashi K; Kondo H
Hum Mutat; 2005 Aug; 26(2):104-12. PubMed ID: 15981244
[TBL] [Abstract][Full Text] [Related]
14. Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding.
Li Y; Chen J; Lu W; McCormick LM; Wang J; Bu G
J Cell Sci; 2005 Nov; 118(Pt 22):5305-14. PubMed ID: 16263759
[TBL] [Abstract][Full Text] [Related]
15. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis.
Kokubu C; Heinzmann U; Kokubu T; Sakai N; Kubota T; Kawai M; Wahl MB; Galceran J; Grosschedl R; Ozono K; Imai K
Development; 2004 Nov; 131(21):5469-80. PubMed ID: 15469977
[TBL] [Abstract][Full Text] [Related]
16. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
Mi K; Johnson GV
J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
[TBL] [Abstract][Full Text] [Related]
17. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells.
Qiu W; Andersen TE; Bollerslev J; Mandrup S; Abdallah BM; Kassem M
J Bone Miner Res; 2007 Nov; 22(11):1720-31. PubMed ID: 17680723
[TBL] [Abstract][Full Text] [Related]
18. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the LRP5 gene to normal variation in peak BMD in women.
Koller DL; Ichikawa S; Johnson ML; Lai D; Xuei X; Edenberg HJ; Conneally PM; Hui SL; Johnston CC; Peacock M; Foroud T; Econs MJ
J Bone Miner Res; 2005 Jan; 20(1):75-80. PubMed ID: 15619672
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.
Rickels MR; Zhang X; Mumm S; Whyte MP
J Bone Miner Res; 2005 May; 20(5):878-85. PubMed ID: 15824861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
